window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 23, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Sanofi

  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    NICE recommends NHS access to teplizumab for early type 1 diabetes

    The UK health watchdog NICE has recommended NHS reimbursement of [...]

    June 22, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Opinion & Events,Pharmaceuticals and therapeutics

    Kling Bio and Sanofi join forces to speed discovery of neutralizing antibodies

    Kling Bio has announced a collaboration and license option agreement [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development

    Kling Bio and Sanofi collaborate to accelerate discovery of next-generation antiviral antibodies

    Biotech company Kling Bio has announced a new collaboration with [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development

    Sanofi to acquire Vicebio for $1.6 billion, boosting next-generation multivalent respiratory vaccines

    Sanofi has agreed to acquire Vicebio Ltd, a biotechnology company [...]

    May 5, 2026
  • Biotech & Pharma Business,Therapeutic Areas

    Adagene secures up to $25 million strategic investment from Sanofi

    Expanded partnership includes new clinical trial and third SAFEbody discovery [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data

    Advarra launches industry council to guide responsible AI use in clinical trials

    A new industry council aims to shape best practices for [...]

    May 5, 2026
  • Biotech & Pharma Business,Opinion & Events

    New anthem shines light on Type 1 diabetes with support from Sanofi

    A new music initiative is raising awareness of autoimmune Type [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Rani reports positive Phase 1 data for oral obesity therapy RT-114
    Categories: Clinical & Regulatory, Drug Delivery & Formulation, Pharmaceuticals and therapeutics, Research & Development
  • Seegene launches global study to evaluate comprehensive PCR testing for respiratory infections
    Categories: Clinical & Regulatory, Digital & Data, Genomics and sequencing, Research & Development
  • Adneuris licenses Phase 3 pain therapy cebranopadol to Conba for Greater China
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top